StemoniX, acquired by AxoSim Email Format

Biotechnology ResearchMinnesota, United States2-10 Employees

StemoniX, acquired by AxoSim, operates in biotechnology research and is located in Maple Grove, Minnesota. In October 2023, AxoSim, Inc. acquired the microBrain-associated assets of Vyant Bio’s StemoniX subsidiary, integrating the platform into AxoSim's offerings. The microBrain platform uses human iPSC-derived organoids to support CNS drug discovery and toxicity testing, featuring cortical neurons and astrocytes that self-organize into functional networks in three dimensions. The platform is noted for consistent performance, enabling high-throughput neurotoxicology, neuromodulation, and drug discovery studies. The organization is small, with 2–10 employees, and information about it is associated with the AxoSim website at axosim.com.

Sign up for free to view info

Company overview Employee directory